Neuro

MIVI Neuroscience Selects Bob Colloton To Lead Worldwide Commercialization Of Innovative Treatment Solution For Ischemic Stroke

EDEN PRAIRIE, Minn., Jan. 23, 2018 /PRNewswire/ — MIVI Neuroscience, a company dedicated to developing best-in-class treatment solutions to improve clinical outcomes for stroke patients, today announced that Bob Colloton has joined the company’s senior management team as Chief Commercial Officer. Bob brings 27 years of proven experience in medical device sales and market development […]

MEDTRONIC RECEIVES FDA CLEARANCE FOR RIPTIDE(TM) ASPIRATION SYSTEM

DUBLIN – January 16, 2018 – Medtronic plc (NYSE:MDT) today announced that the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio. The Riptide Aspiration System is designed to retrieve thrombus […]

Cerebrotech Visor™ Receives FDA Clearance

PLEASANTON, Calif., Jan. 4, 2018 /PRNewswire/ — Cerebrotech Medical Systems, an innovative medical device company developing neurotechnology solutions, has received clearance from the Food and Drug Administration, or FDA, for the Cerebrotech Visor, previously known as the CMS-5000™ Intracranial Fluids Monitor™. The clearance includes a broad indication for use as an aid in the […]

Robocath raises a total of €6.4 million ($7.6M) in 2017

Robocath receives an additional €1.25 million financial contribution from Crédit Agricole Innovations et Territoires (CAIT), an innovation fund managed by Supernova Invest. In line with the company’s growth strategy, the new funding aims to increase the resources available to market the R-OneTM product and launch the development of the next generation of […]

InspireMD Announces Expansion of its Distribution Network for CGuard™ EPS in Australia, New Zealand and Vietnam

TEL AVIV, lSRAEL, Dec. 04, 2017 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed Diverse Devices Pty Ltd as its exclusive distributor for Australia and New Zealand, and has signed Do Gia Production […]

MRI Interventions’ ClearPoint® NeuroNavigation System Achieves 2000th Procedure Milestone

IRVINE, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced the 2000th procedure completed with the ClearPoint NeuroNavigation System. The procedure was done by Dr. William Anderson at Johns Hopkins University. In the fall of 1998, a group of researchers at Johns Hopkins University imagined a novel […]

Stryker Announces Publication of the DAWN Trial Results in the New England Journal of Medicine

KALAMAZOO, Michigan, USA, Nov. 13, 2017 /PRNewswire/ — The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy. Currently, less than one in 10 patients suffering from an ischemic stroke receives thrombectomy, […]

FDA Approves Stryker’s Neuroform Atlas Stent System to Treat Wide Neck Aneurysms

KALAMAZOO, Michigan, USA, Nov. 9, 2017 /PRNewswire/ — Stryker Corporation announced today that the U.S. Food and Drug Administration has approved the Neuroform Atlas™ Stent System for marketing under a humanitarian device exemption (HDE). The device is to be utilized in conjunction with neurovascular embolic coils for the treatment of wide neck, […]